| Catalog Code: | NB100-2547 |
| Product Type: | Primary Antibody |
| Product Name: | LAMC2 Antibody |
| List Price: | 195 |
| Clonality: | Polyclonal |
| Gene ID: | 3918 |
| Host: | Goat |
| Isotype: | IgG |
| Product Description: | Goat Polyclonal anti-LAMC2 |
| Cross Reactivity: | Expected cross-reactivity based upon sequence homology: Human |
| Species Summary: | Hu |
| Background: | **Please note, this product is one of a range of Investigative Grade antibodies, made against targets that have limited or no commercial antibodies available to them and for which there are no data on the expression of the protein in the range of common c |
| Alternate Names: | anti-LAMC2 antibody, anti-laminin antibody, anti-gamma 2 antibody, anti-HGNC:6493 antibody, anti-B2T antibody, anti-BM600 antibody, anti-EBR2 antibody, anti-EBR2A antibody, anti-LAMB2T antibody, anti-LAMNB2antibody, anti-BM600-100kDa antibody, anti-kalini |
| Immunogen: | Synthetic peptide: C-QKVDTRAKNAGVTIQD, representing the internal region of the human protein according to NP_005553.1; NP_061486.1 |
| Specificity: | This antibody is expected to recognise both reported isoforms (NP_005553.1; NP_061486.1) |
| Purity: | Immunogen affinity purified |
| Buffer: | Tris-saline containing 0.02% Na azide [pH7.3] with 0.5% BSA |
| Packaging: | 0.1 mg Immunogen affinity purified Goat antisera. |
| Package Size: | 0.1 mg |
| Concentration: | 0.5 mg/ml |
| Uses: | Peptide ELISA: antibody detection limit dilution 1:16,000.Western Blot: Preliminary experiments gave bands at approx 170-kDa and 55-60kDa in Human Lung lysates after 1µg/ml antibody staining. Please note that currently we cannot find an explanation |
| Application Summary: | WB |
| General References: | Amin K, Janson C, Seveus L, Miyazaki K, Virtanen I, Venge P. . Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics.. Respir Res. 2005 Sep 22;6:110. . PMID: 16179086 |
| Notes Main: | **Please note, this product is one of a range of Investigative Grade antibodies, made against targets that have limited or no commercial antibodies available to them and for which there are no data on the expression of the protein in the range of common c |